Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
europe blog main
fda
3
×
life sciences
national blog main
san francisco blog main
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deerfield management
detroit blog main
detroit top stories
europe top stories
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
ipo
medicines
3
×
bio
covid
new
roundup
acquisitions
activity
announced
approvals
biogen
biotech
black
cancer
ceo
clamped
clinic
collabs
companies
daniel
deal
delays
developing
diamond
drug
economic
eluded
fast
fda
gilead
gilead’s
help
hopes
including
introduce
isn’t
lead
leading
lines
lot
Language
unset
Current search:
medicines
×
cancer
×
" san francisco blog main "
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic